Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Tactics used x Hedge Fund & MM to acquire shareholder stock

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Nov 16, 2022 7:54pm

176 Views

Post# 35105292

RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

And right on cue we have Hcallahan44 and Buckhenry trying again to shift the focus off themselves by attempting the guilibility tactic of just being "one of us" who has been "suckered" in by "one of dem city slickers". Yah .. right. So how long have they been posting on this message board? Not very long from what I can see.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland